Note 15. Equity Transactions (Tables)

12 Months Ended

Jun. 30, 2013

Stockholders' Equity Note [Abstract]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	Fiscal Year Ended June 30,
	2013		2012
Anti-dilutive stock options		2,269,088		2,915,338
Anti-dilutive warrants		500,000		500,000
Anti-dilutive shares for convertible notes payable		8,230,769		8,230,769
Total anti-dilutive shares		10,999,857		11,646,107

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Options			Weighted Average Exercise Price
Outstanding as of July 1, 2011		3,016,338		$	5.42
Granted		-			-
Exercised		-			-
Terminated		(61,500	)		1.44
Expired		(39,500	)		2.79
Outstanding as of June 30, 2012		2,915,338			5.54
Granted		-			-
Exercised		-			-
Terminated		(24,000	)		0.75
Expired		(92,500	)		1.47
Outstanding as of June 30, 2013		2,798,838		$	5.72
Exercisable at June 30, 2012		2,915,338		$	5.54
Exercisable at June 30, 2013		2,798,838		$	5.72

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

Range of Exercise Price					Outstanding		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)		Exercisable		Weighted Average Exercise Price
$	0.14	-	$	0.15		629,750	$	0.14		5.3		629,750	$	0.14
$	2.96	-	$	2.96		50,000		2.96		4.8		50,000		2.96
$	3.05	-	$	3.05		183,600		3.05		4.4		183,600		3.05
$	3.13	-	$	3.13		50,000		3.13		2.4		50,000		3.13
$	3.86	-	$	4.10		72,000		3.97		2.4		72,000		3.97
$	5.29	-	$	6.93		931,170		6.38		1.6		931,170		6.38
$	7.48	-	$	7.90		26,500		7.88		1.9		26,500		7.74
$	9.90	-	$	10.89		845,818		10.01		0.4		845,818		10.01
$	14.90	-	$	14.90		10,000		14.90		0.8		10,000		14.90
$	0.14	-	$	14.90		2,798,838	$	5.72		2.5		2,798,838	$	5.72